Related Experiment Video
Updated: Jul 12, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Functional Dyspepsia: A New Rome III Paradigm
Smita L S Halder1, Nicholas J Talley
1Nicholas J. Talley, MD, PhD Department of Internal Medicine, Mayo Clinic Jacksonville, 4500 San Pablo Road, Davis 6-72 E, Jacksonville, FL 32224, USA. talley.nicholas@mayo.edu.
Functional dyspepsia (FD) treatment is challenging, with limited evidence for many therapies. Current approaches focus on Helicobacter pylori eradication and symptom-specific treatments, though new options are emerging.
Area of Science:
- Gastroenterology
- Functional Gastrointestinal Disorders
Background:
- Functional dyspepsia (FD) is a prevalent condition in gastroenterology.
- Rome III criteria (2006) introduced new symptom-based classifications for FD.
- These classifications suggest distinct pathophysiologies and treatment targets for symptom subgroups.
Purpose of the Study:
- To review the current understanding and management of functional dyspepsia.
- To evaluate the efficacy of existing and emerging treatments for FD.
Main Methods:
- Literature review of current gastroenterological practice and research on functional dyspepsia.
- Analysis of diagnostic criteria, treatment strategies, and emerging therapies.
Main Results:
- Many current FD treatments have limited or short-lived efficacy.
- Helicobacter pylori eradication is a first-line strategy.
- Antisecretory agents for epigastric pain, prokinetics for meal-related symptoms show limited benefit.
- Psychological therapies and emerging treatments like gastric fundus relaxors show promise.
Conclusions:
- Functional dyspepsia management remains a significant clinical challenge.
- Therapy should be guided by putative pathophysiologic mechanisms.
- Further research is needed for novel therapeutic agents and psychological interventions.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
